JPM-2024-Ginkgo-Bioworks-Final-3.pdf

1、Ginkgo Bioworks JP Morgan Conference 2024Property of Ginkgo Bioworks 1Grow with GinkgoJ.P.Morgan Healthcare ConferenceJason KellyCo-Founder&CEOJanuary 10,20241Ginkgo Bioworks JP Morgan Conference 2024Property of Ginkgo Bioworks 2Forward-Looking StatementsThis presentation,the conference call and web

2、cast(together,the“presentation”)contain certain forward-looking statements within the meaning of the federal securities laws,including statements regarding our plans and strategies,including with respect to our balance sheet and cash runway,current expectations,operations and anticipated results of

3、operations,both business and financial,including opportunities for increased operational efficiency,growth of pharmaceutical partnerships,potential customer success,including successful application of our offerings by our customers,expectations with regard to revenue,and the market environment,all o

4、f which are subject to known and unknown risks,uncertainties and other factors that may cause our actual results,performance or achievements,market trends,or industry results to differ materially from those expressed or implied by such forward-looking statements.These forward-looking statements gene

5、rally are identified by the words believe,can,project,potential,expect,anticipate,estimate,intend,strategy,future,opportunity,plan,may,should,will,would,will be,will continue,will likely result,and similar expressions.Forward-looking statements are predictions,projections and other statements about

6、future events that are based on current expectations and assumptions and,as a result,are subject to risks and uncertainties.Many factors could cause actual future events to differ materially from the forward-looking statements in this presentation,including but not limited to:(i)volatility in the pr